Purchase Order 75N92025P00333
Award Date
9/1/25
Potential Completion Date
8/31/26
Potential Value
$147K
Funding Federal Agency
National Human Genome Research Institute
Contracting Federal Agency
National Heart Lung and Blood Institute
Awardee
Ultima Genomics, Inc.
Ultimate Awardee
Not listed
NAICS Category
621511 - Medical Laboratories
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Fremont, CA 94538, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the National Human Genome Research Institute (NHGRI) to acquire DNA sequencing reagents from Ultima Genomics, Inc. The $19,858.00 firm-fixed-price purchase order will support the "Project Kastner NF GRASP" initiated by Dr. Dan Kastner at NHGRI on April 4, 2014. The award has no set-aside designation. Ultima Genomics is a for-profit manufacturer of DNA sequencing technology, including the UG100 platform aimed at providing scalable $100 genome...
The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $1.025 million firm-fixed-price purchase order contract to Ultima Genomics, Inc. of Newark, California. Under the terms of the contract, Ultima Genomics will provide one of its UG100-V DNA sequencers to the NIH's Vaccine Research Center in Bethesda, Maryland by March 19, 2023. The sequencer will support high-throughput next-generation sequencing capabilities,...
This is a firm fixed price purchase order awarded by the National Human Genome Research Institute (NHGRI), which is part of the National Institutes of Health (NIH), a civilian agency. The contract, valued at $770,306.04, was awarded to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract does not have a set-aside designation. Under this contract, Illumina will provide a range of goods and services to support genomic sequencing...
This is a firm fixed price delivery order awarded by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH), to Illumina, Inc. The $44,187.38 contract is for the provision of Illumina's sequencing systems, reagents, and related consumables and services to support genomic research and analysis activities. The contract has no set-aside designation and is not associated with a larger acquisition vehicle. Illumina, a manufacturer of genetic and...
This is a firm fixed price delivery order awarded by the National Human Genome Research Institute (NHGRI), a civilian agency, to Illumina, Inc. for $16,447.05. The contract is for the provision of reagents needed by NHGRI staff scientists for preparation of PCR-free whole genome libraries and sequencing. The contract has a period of performance through March 31, 2025 and does not have a set-aside designation. Illumina, a for-profit manufacturer of genomic sequencing instruments and reagents, has...
This firm fixed-price delivery order was awarded to Illumina, Inc. by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH), a civilian agency. The $9,909.50 contract is not set-aside and provides for the delivery of Illumina's proprietary sequencing systems, reagents, and associated services to support genomic sequencing and analysis research at NHGRI. Illumina has a history of providing similar goods and services to other federal...
This is a $164,633.80 firm fixed price purchase order contract awarded by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH), to Illumina, Inc. The contract is for the provision of sequencing systems, reagents, and related services to support genomic sequencing and analysis research. Illumina, a manufacturer of genetic analysis instruments and reagents, has previously held prime contracts and subcontracts with various federal agencies...
The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a $57,000 purchase order to Oxford Nanopore Technologies Inc. to procure Grid ION Mk1 sequencing devices. The one-year firm fixed price contract, running from July 2021 through July 2022, will provide the sequencing devices requested in Solicitation Number NIH-NHGRI-21-100-SOL titled "To Procure Grid ION Mk1 Sequencing Device." As the parent agency of the...
This is a firm fixed-price purchase order awarded by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The $15,575 contract is for the delivery of Illumina's proprietary sequencing systems, reagents, and related products and services to support the Institute's genomic research and diagnostics activities. This award is not associated with any...
This is a firm fixed-price delivery order awarded by the National Human Genome Research Institute (NHGRI) to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $498,777.14 contract is to provide Illumina sequencing systems, reagents, and services to support genomic sequencing and analysis for NHGRI's research and diagnostic needs. Illumina has been awarded multiple federal contracts and sub-grants by agencies such as the National...